Elixinol Wellness (ASX:EXL) Ending Cash Position: A$1.41 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Elixinol Wellness Ending Cash Position?

Elixinol Wellness ASX:EXL Ending Cash Position is A$1.41 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Elixinol Wellness's Ending Cash Position for the quarter that ended in Dec. 2025 was A$1.41 Mil.

Elixinol Wellness's quarterly Ending Cash Position increased from Dec. 2024 (A$1.08 Mil) to Jun. 2025 (A$1.09 Mil) and increased from Jun. 2025 (A$1.09 Mil) to Dec. 2025 (A$1.41 Mil).

Elixinol Wellness's annual Ending Cash Position increased from Dec. 2023 (A$0.71 Mil) to Dec. 2024 (A$1.08 Mil) and increased from Dec. 2024 (A$1.08 Mil) to Dec. 2025 (A$1.41 Mil).

Elixinol Wellness Ending Cash Position Related Terms

Elixinol Wellness Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Elixinol Wellness's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixinol Wellness Ending Cash Position Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 12.65 2.86 0.71 1.08 1.41

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 1.58 1.08 1.09 1.41

Elixinol Wellness Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Elixinol Wellness's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1.078+0.327
=1.41

Elixinol Wellness's Ending Cash Position for the quarter that ended in Dec. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.087+0.318
=1.41

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of A$1.41 Mil mean?
Elixinol Wellness (ASX:EXL) has a Ending Cash Position of A$1.41 Mil as of Dec. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Elixinol Wellness and its competitors.
Is Elixinol Wellness' Ending Cash Position too high?
Elixinol Wellness' current Ending Cash Position is A$1.41 Mil.
How does Elixinol Wellness' Ending Cash Position compare to ZTS and UTHR?
Elixinol Wellness' Ending Cash Position of A$1.41 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Elixinol Wellness and its competitors. Elixinol Wellness's current Ending Cash Position is A$1.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elixinol Wellness stock overvalued right now?
Based on GuruFocus' analysis, Elixinol Wellness (ASX:EXL) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 70% below its estimated fair value. The current Ending Cash Position is A$1.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Elixinol Wellness (ASX:EXL), the current Ending Cash Position is A$1.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Elixinol Wellness Business Description

Other Exchanges ELLXF:USAE8M:Germany
Address 51 - 53 Riversdale Road, Newtown, VIC, AUS, 3220
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.